Salar Khaledian

Salar Khaledian

Auto-generated profile, based on publicly available information

Salar Khaledian

Infectious Diseases Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2019 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
HRHamid Rahmani
Hamid Rahmani
AFAli Fattahi
Ali Fattahi
KSKomail Sadrjavadi
Komail Sadrjavadi
SKSalar Khaledian
Salar Khaledian
YSYalda Shokoohinia
Yalda Shokoohinia
Purpose: The aim of this study is to prepare 5-fluorouracil (5-FU) loaded silk fibroin nanoparticles(SFNPs) and to achieve a controlled release delivery system with the high loading capacity. Methods: SFNPs with 1:1, 1:3, and 1:10 ratios of 5-FU to silk fibroin were prepared. SFNPswere characterized by Fourier-transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD)analysis, Scanning electron microscope (SEM), and Transmission electron microscope (TEM).Loading efficiency, in vitro release, and cell viability were studied for optimal SFNPs. Results: The ratio of 1:1 was optimal formulation with the size and polydispersity index (PDI)of 221.03 nm and 0.093 before freeze drying, and 286.7 nm and 0.154 after freeze dryingby lactose, respectively. The loading efficiency and loading content of this ratio were 52.32%and 34.35%, respectively. FT-IR and XRD analysis indicated the conformational change (fromrandom coil to β-sheet) in the structure of nanoparticles by increasing amount of the drug, whichcaused the smaller size, the higher loading efficiency, and the slower release pattern. The drugloadednanoparticles reached to the half maximal inhibitory concentration (IC50) that werecomparable with free drug on MCF7 (human breast cancer) cell line. Conclusion: This study was planned to achieve a promising controlled release drug deliverysystem for carrying 5-FU, as a potent anticancer drug. SFNPs were found proper candidates fordelivery of a hydrophilic drug such as 5-FU.

1 January 2020 in Colloids and Surfaces A: Physicochemical and Engineering Aspects
Verified
Journal Article
Closed access
SKSalar Khaledian
Salar Khaledian
MAMohadese Abdoli
Mohadese Abdoli
MSMohsen Shahlaei
Mohsen Shahlaei
LBLeila Behbood
Leila Behbood
DKDanial Kahrizi
Danial Kahrizi
SMSajad Moradi
Sajad Moradi

10 March 2024 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
SKSalar Khaledian
Salar Khaledian
GMGhobad Mohammadi
Ghobad Mohammadi
MAMohadese Abdoli
Mohadese Abdoli
AFArad Fatahian
Arad Fatahian
AFArya Fatahian
Arya Fatahian
RFReza Fatahian
Reza Fatahian
Spinal cord injury (SCI) is an important factor in sensory and motor disorders that affects thousands of people every year. Currently, despite successes in basic science and clinical research, there are few effective methods in the treatment of chronic and acute spinal cord injuries. In the last decade, the use of 3D printed scaffolds in the treatment of SCI had satisfactory and promising results. By providing a microenvironment around the injury site and in combination with growth factors or cells, 3D printed scaffolds help in axon regeneration as well as neural recovery after SCI. Here, we provide an overview of tissue engineering, 3D printing scaffolds, the different polymers used and their characterization methods. This review highlights the recent encouraging applications of 3D printing scaffolds in developing the novel SCI therapy.